We conclude that there is no clear evidence for compensatory up-regulation of protease inhibitors, such as ACT and SLPI, in healthy (asymptomatic) subjects with severe AAT deficiency. This evidence concerns the gene SERPINA3 and alpha 1-antitrypsin deficiency.